Clinical trials
Withdrawn Phase 1/2 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 27 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| F2G Ltd | 2 |
| Novartis Pharmaceuticals | 2 |
| Actinium Pharmaceuticals | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Bio-Path Holdings, Inc. | 1 |
| Children's Oncology Group | 1 |
| Erasca, Inc. | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Genzyme, a Sanofi Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 27 |
| Myelodysplastic Syndromes | 12 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 7 |
| Leukemia | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Leukemia, Myelomonocytic, Chronic | 5 |
| Burkitt Lymphoma | 4 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Mantle-Cell | 4 |
Trials
Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.